Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rotator Cuff Injuries | 4 | 2022 | 46 | 2.900 |
Why?
|
| Brain Concussion | 5 | 2021 | 59 | 2.700 |
Why?
|
| Shoulder Joint | 3 | 2022 | 90 | 2.110 |
Why?
|
| Rotator Cuff | 3 | 2021 | 44 | 2.090 |
Why?
|
| Athletic Injuries | 3 | 2021 | 91 | 1.970 |
Why?
|
| Football | 2 | 2021 | 43 | 1.510 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 2 | 2020 | 18 | 1.410 |
Why?
|
| Arthroscopy | 8 | 2023 | 94 | 1.400 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2019 | 74 | 1.310 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2019 | 102 | 1.250 |
Why?
|
| Baseball | 2 | 2020 | 17 | 1.160 |
Why?
|
| Anterior Cruciate Ligament Injuries | 3 | 2020 | 40 | 0.990 |
Why?
|
| Spinal Stenosis | 3 | 2011 | 26 | 0.990 |
Why?
|
| Back Injuries | 2 | 2020 | 6 | 0.930 |
Why?
|
| Lumbar Vertebrae | 3 | 2011 | 148 | 0.920 |
Why?
|
| Femoracetabular Impingement | 2 | 2019 | 11 | 0.870 |
Why?
|
| Basketball | 1 | 2022 | 3 | 0.860 |
Why?
|
| Decompression, Surgical | 3 | 2021 | 87 | 0.850 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2022 | 111 | 0.830 |
Why?
|
| Athletic Performance | 1 | 2022 | 31 | 0.830 |
Why?
|
| Radiography | 2 | 2022 | 813 | 0.810 |
Why?
|
| Knee Dislocation | 1 | 2021 | 5 | 0.810 |
Why?
|
| Knee Injuries | 1 | 2021 | 53 | 0.780 |
Why?
|
| Golf | 1 | 2020 | 2 | 0.770 |
Why?
|
| Joint Diseases | 1 | 2020 | 49 | 0.730 |
Why?
|
| Retrospective Studies | 11 | 2022 | 8496 | 0.730 |
Why?
|
| Joint Capsule | 1 | 2019 | 6 | 0.730 |
Why?
|
| Humeral Head | 1 | 2019 | 7 | 0.730 |
Why?
|
| Meniscectomy | 1 | 2019 | 3 | 0.720 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2019 | 19 | 0.710 |
Why?
|
| Aspirin | 1 | 2020 | 156 | 0.700 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 161 | 0.680 |
Why?
|
| Spinal Fusion | 2 | 2011 | 85 | 0.650 |
Why?
|
| Physical Examination | 1 | 2019 | 149 | 0.640 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 153 | 0.630 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 103 | 0.630 |
Why?
|
| Hockey | 1 | 2017 | 9 | 0.620 |
Why?
|
| Orthopedic Procedures | 1 | 2019 | 128 | 0.620 |
Why?
|
| Ambulatory Care | 1 | 2019 | 181 | 0.610 |
Why?
|
| Humans | 33 | 2023 | 86678 | 0.610 |
Why?
|
| Knee Joint | 3 | 2023 | 168 | 0.550 |
Why?
|
| Seasons | 3 | 2021 | 223 | 0.520 |
Why?
|
| Patella | 1 | 2014 | 32 | 0.500 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 67 | 0.480 |
Why?
|
| Osteoarthritis, Knee | 1 | 2014 | 63 | 0.480 |
Why?
|
| Databases, Factual | 4 | 2019 | 816 | 0.430 |
Why?
|
| Incidence | 3 | 2021 | 1578 | 0.410 |
Why?
|
| Logistic Models | 3 | 2020 | 1188 | 0.410 |
Why?
|
| Range of Motion, Articular | 2 | 2022 | 154 | 0.390 |
Why?
|
| Cadaver | 2 | 2022 | 185 | 0.390 |
Why?
|
| Allografts | 2 | 2022 | 172 | 0.370 |
Why?
|
| Cohort Studies | 4 | 2020 | 2768 | 0.370 |
Why?
|
| Treatment Outcome | 6 | 2021 | 7998 | 0.370 |
Why?
|
| Male | 12 | 2021 | 40988 | 0.360 |
Why?
|
| Hip Joint | 2 | 2019 | 55 | 0.340 |
Why?
|
| Lower Extremity | 2 | 2021 | 84 | 0.340 |
Why?
|
| Osteogenesis | 3 | 2020 | 243 | 0.320 |
Why?
|
| United States | 4 | 2022 | 6681 | 0.320 |
Why?
|
| Surgical Wound Infection | 2 | 2020 | 184 | 0.320 |
Why?
|
| Growth Differentiation Factor 2 | 2 | 2020 | 152 | 0.300 |
Why?
|
| Eosinophilia | 1 | 2007 | 84 | 0.300 |
Why?
|
| Low Back Pain | 1 | 2007 | 40 | 0.290 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2007 | 102 | 0.290 |
Why?
|
| Physical Therapy Modalities | 1 | 2007 | 84 | 0.290 |
Why?
|
| Risk Factors | 4 | 2020 | 5420 | 0.270 |
Why?
|
| Interferon-gamma | 1 | 2007 | 444 | 0.270 |
Why?
|
| Comorbidity | 2 | 2019 | 944 | 0.260 |
Why?
|
| Middle Aged | 7 | 2020 | 25040 | 0.260 |
Why?
|
| Aged | 6 | 2022 | 18423 | 0.250 |
Why?
|
| Patient Readmission | 2 | 2019 | 329 | 0.240 |
Why?
|
| Pilot Projects | 2 | 2019 | 840 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2007 | 558 | 0.240 |
Why?
|
| Disability Evaluation | 3 | 2011 | 136 | 0.240 |
Why?
|
| Cell Differentiation | 3 | 2020 | 1458 | 0.230 |
Why?
|
| Autografts | 1 | 2022 | 28 | 0.220 |
Why?
|
| Rupture | 1 | 2022 | 63 | 0.220 |
Why?
|
| Return to Sport | 1 | 2022 | 4 | 0.220 |
Why?
|
| Female | 8 | 2020 | 44550 | 0.210 |
Why?
|
| Adult | 6 | 2023 | 25659 | 0.210 |
Why?
|
| Biomechanical Phenomena | 1 | 2022 | 457 | 0.190 |
Why?
|
| Tissue Adhesions | 1 | 2020 | 50 | 0.190 |
Why?
|
| Injections, Intra-Articular | 1 | 2020 | 27 | 0.190 |
Why?
|
| STAT Transcription Factors | 1 | 2020 | 18 | 0.180 |
Why?
|
| Janus Kinases | 1 | 2020 | 23 | 0.180 |
Why?
|
| Acromion | 1 | 2019 | 3 | 0.180 |
Why?
|
| Acellular Dermis | 1 | 2019 | 4 | 0.180 |
Why?
|
| Second-Look Surgery | 1 | 2019 | 4 | 0.180 |
Why?
|
| Competitive Behavior | 1 | 2020 | 28 | 0.180 |
Why?
|
| Weight-Bearing | 1 | 2019 | 61 | 0.180 |
Why?
|
| Menisci, Tibial | 1 | 2019 | 25 | 0.180 |
Why?
|
| Leptin | 1 | 2020 | 105 | 0.180 |
Why?
|
| Asthma | 1 | 2007 | 955 | 0.170 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 98 | 0.170 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2019 | 23 | 0.170 |
Why?
|
| Travel | 1 | 2019 | 68 | 0.170 |
Why?
|
| Bioprinting | 1 | 2019 | 13 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 263 | 0.170 |
Why?
|
| Anesthesia | 1 | 2020 | 164 | 0.160 |
Why?
|
| Hydrogels | 1 | 2019 | 82 | 0.160 |
Why?
|
| Young Adult | 2 | 2020 | 5980 | 0.160 |
Why?
|
| Medicare | 1 | 2022 | 410 | 0.160 |
Why?
|
| Risk | 1 | 2020 | 674 | 0.160 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 106 | 0.160 |
Why?
|
| Sprains and Strains | 1 | 2017 | 12 | 0.160 |
Why?
|
| Orthopedics | 1 | 2019 | 124 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2019 | 680 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 413 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2020 | 408 | 0.150 |
Why?
|
| Postoperative Complications | 3 | 2023 | 2207 | 0.150 |
Why?
|
| Upper Extremity | 1 | 2017 | 52 | 0.150 |
Why?
|
| Tissue Engineering | 1 | 2019 | 181 | 0.150 |
Why?
|
| Oxygen | 1 | 2022 | 726 | 0.140 |
Why?
|
| Sports Medicine | 1 | 2017 | 56 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 222 | 0.140 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 243 | 0.140 |
Why?
|
| Reoperation | 1 | 2019 | 597 | 0.140 |
Why?
|
| Tenocytes | 1 | 2016 | 4 | 0.140 |
Why?
|
| Achilles Tendon | 1 | 2016 | 15 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2017 | 131 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1807 | 0.140 |
Why?
|
| Prospective Studies | 3 | 2011 | 4214 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2019 | 573 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 373 | 0.130 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 37 | 0.130 |
Why?
|
| Patient Selection | 1 | 2019 | 686 | 0.130 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 116 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6513 | 0.120 |
Why?
|
| Hospitalization | 1 | 2019 | 851 | 0.120 |
Why?
|
| Head Protective Devices | 1 | 2012 | 20 | 0.110 |
Why?
|
| Adolescent | 2 | 2023 | 8984 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2011 | 2504 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2011 | 303 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2019 | 1010 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2020 | 265 | 0.080 |
Why?
|
| Eosinophil Major Basic Protein | 1 | 2007 | 1 | 0.080 |
Why?
|
| Rats, Inbred BN | 1 | 2007 | 37 | 0.080 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2007 | 16 | 0.080 |
Why?
|
| Leukotrienes | 1 | 2007 | 20 | 0.080 |
Why?
|
| Sex Factors | 1 | 2011 | 1055 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 455 | 0.080 |
Why?
|
| Spinal Canal | 1 | 2007 | 4 | 0.080 |
Why?
|
| Spondylolisthesis | 1 | 2007 | 12 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2011 | 770 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2007 | 86 | 0.080 |
Why?
|
| Ovalbumin | 1 | 2007 | 109 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 121 | 0.080 |
Why?
|
| Macrophages, Alveolar | 1 | 2007 | 55 | 0.080 |
Why?
|
| Adoptive Transfer | 1 | 2007 | 168 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2007 | 127 | 0.070 |
Why?
|
| Cysteine | 1 | 2007 | 135 | 0.070 |
Why?
|
| Antigens | 1 | 2007 | 228 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1673 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1852 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 272 | 0.070 |
Why?
|
| Cell Line | 2 | 2020 | 2469 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3642 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2016 | 615 | 0.060 |
Why?
|
| Wound Closure Techniques | 1 | 2023 | 14 | 0.060 |
Why?
|
| Prognosis | 1 | 2011 | 3680 | 0.060 |
Why?
|
| Bandages | 1 | 2023 | 41 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1981 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1579 | 0.050 |
Why?
|
| Animals | 4 | 2020 | 26590 | 0.050 |
Why?
|
| Rats | 1 | 2007 | 3992 | 0.050 |
Why?
|
| Adipogenesis | 1 | 2020 | 38 | 0.050 |
Why?
|
| Mice | 3 | 2020 | 11356 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 18 | 0.040 |
Why?
|
| North America | 1 | 2019 | 180 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2019 | 52 | 0.040 |
Why?
|
| Growth Differentiation Factors | 1 | 2019 | 57 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1921 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 77 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 790 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 493 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 420 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 193 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2019 | 157 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 715 | 0.040 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2016 | 47 | 0.030 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2016 | 32 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 105 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 154 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 51 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 104 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2016 | 126 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3362 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 273 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 1015 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 969 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 704 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 5214 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 1718 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 3243 | 0.020 |
Why?
|